logo
ProjectForthcoming

Spatial Code of Tumors: Mapping, Modeling, and Mechanism

One of 1,906 projects Taiyo tracks in Israel.

Source: EU Funding & Tenders Portal

Tumors are ecosystems, where malignant and non-malignant cells interact within an organized tumor microenvironment (TME). Understanding how these interactions drive complex pathology such as metastasis and response to treatment is a major challenge in cancer biology. While spatial proteomics technologies have begun to reveal the architectural complexity of human tumors, current approaches are limi

Status
Prospective
Location
Israel
Updated
19 Nov 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Spatial Code of Tumors: Mapping, Modeling, and Mechanism

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Spatial Code of Tumors: Mapping, Modeling, and Mechanism” is an infrastructure initiative, located in Israel. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Tumors are ecosystems, where malignant and non-malignant cells interact within an organized tumor microenvironment (TME). Understanding how these interactions drive complex pathology such as metastasis and response to treatment is a major challenge in cancer biology. While spatial proteomics technologies have begun to reveal the architectural complexity of human tumors, current approaches are limited in scale, standardization, and functional interpretability. Existing platforms measure only dozens of proteins, analysis pipelines are fragmented, hindering cross-cohort integration, and functional studies rarely preserve the TME’s architecture. This project addresses the question: what are the spatially organized intercellular networks that govern therapeutic response and resistance in human tumors. To answer it, it proposes three interconnected aims to develop new technologies to map such networks at scale, interrogate them using a common modeling framework and perform mechanistic studies to elucidate their function. In Aim 1, we will develop KiloPlex, a novel spatial proteomics method to image 1000 proteins in intact human tumors using combinatorial staining and AI-based decomposition. We will apply KiloPlex to profile 1000 tumors from 10 cancer types, generating a comprehensive spatial proteomics atlas with unprecedented molecular resolution. In Aim 2, we will build an AI foundation model trained on this data and existing data to enable generalizable analysis of tissue organization and cell-cell interactions across cancer types. In Aim 3, we will couple spatial proteomics with ex vivo cultures to perturb and probe tumor-related immune populations and drug-targeted T cells, to understand their function in mediating response to checkpoint inhibitors. Together, these aims will establish a new framework for spatially resolved, functional tumor profiling, opening the door to informed biomarkers, therapeutic targets, and precision immunotherapy strategies.

Location

Country

Israel

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Article published date

2026-10-15

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project